MoneyWorks4Me

Zenotech Labs. - Quaterly Results

29 Jul 2026 Evaluate
The June 2026 quarter revenue stood at Rs. 106.12 millions, up 10.05% as compared to Rs. 96.43 millions during the corresponding quarter last year.The Net Loss for the quarter ended June 2026 is Rs. -4.55 millions as compared to Net Profit of Rs. 9.89 millions of corresponding quarter ended June 2025The Operating Profit of the company witnessed a decrease to 13.02 millions from 30.50 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202606 202506 % Var 202606 202506 % Var 202603 202503 % Var
Sales 106.12 96.43 10.05 106.12 96.43 10.05 436.14 430.47 1.32
Other Income 4.36 5.88 -25.85 4.36 5.88 -25.85 23.09 15.49 49.06
PBIDT 13.02 30.50 -57.31 13.02 30.50 -57.31 114.98 157.29 -26.90
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBDT 13.02 30.50 -57.31 13.02 30.50 -57.31 113.03 176.52 -35.97
Depreciation 19.02 17.74 7.22 19.02 17.74 7.22 71.13 69.60 2.20
PBT -6.00 12.76 -147.02 -6.00 12.76 -147.02 41.90 106.92 -60.81
TAX -1.45 2.87 -150.52 -1.45 2.87 -150.52 52.61 50.79 3.58
Deferred Tax -1.45 0.65 -323.08 -1.45 0.65 -323.08 47.72 25.86 84.53
PAT -4.55 9.89 -146.01 -4.55 9.89 -146.01 -10.71 56.13 -119.08
Equity 610.31 610.31 0.00 610.31 610.31 0.00 610.31 610.31 0.00
PBIDTM(%) 12.27 31.63 -61.21 12.27 31.63 -61.21 26.36 36.54 -27.85

Zenotech Labs. Share Price

44.01 0.01 (0.02%)
12-Aug-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1935.00
Dr. Reddys Labs. 1198.95
Cipla 1461.55
Lupin 2264.70
Zydus Lifesciences 1204.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: